Subgroups according to BASDAI/ASDAS category (baseline)

Genetic and Molecular Distinctions Between Axial Psoriatic Arthritis and Radiographic Axial Spondyloarthritis: Post Hoc Analyses from Four Phase 3 Clinical Trials

Baseline values and 3-month response in subgroups according to CRP

Association of body mass index on disease activity in axial spondyloarthritis: systematic review and meta-analysis

Disease activity status at baseline stratified by BASDAI and ASDAS.

Construct validity and responsiveness of the simplified version of Ankylosing Spondylitis Disease Activity Score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis, Health and Quality of Life Outcomes

The clinical utility of faecal calprotectin in patients with differentiated and undifferentiated spondyloarthritis: Relevance and clinical implications

Baseline values and 3-month response in subgroups according to CRP

Measuring quality of life of patients with axial spondyloarthritis for economic evaluation

Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial - The Lancet

Association of body mass index on disease activity in axial spondyloarthritis: systematic review and meta-analysis

Effect of body mass index on treatment response of biologic/targeted-synthetic DMARDs in patients with rheumatoid arthritis, psoriatic arthritis or axial spondyloarthritis. A systematic review - ScienceDirect